Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Hims and Hers (HIMS) PT Raised to $24 at Citi
November 5, 2024 6:31 AM ESTCiti analyst Daniel Grosslight raised the price target on Hims and Hers (NYSE: HIMS) to $24.00 (from $20.00) while maintaining a Neutral rating.
The analyst comments "HIMS results continue to impress, with another significant beat-and-raise across the board (LINK). Given much of this outperformance was... More
